Effect of Two Types of Homeopathic Treatment on Hormone Balance in Women with Polycystic Ovary Syndrome (PCOS)

A Prospective Comparative Evaluation Of The Effect Of Folliculinum Vs Constitutional Homoeopathic Medicine In Cases Of PCOS, Assessed By The FSH/LH Ratio - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095531

Enrollment

Registered

2025-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Folliculinum: Potency and dose: 30c,200c,1M according to susceptibility Route of administration: orally Total duration of intervention: 12 month Control Intervention1: Constitutional h

Eligibility

Inclusion criteria

Inclusion criteria: Female patients aged 18 to 40 years Suffering from PCOS for a minimum duration of 6 months and not more than 5 years Diagnosed with PCOD based on Rotterdam criteria (at least 2 of 3: menstrual irregularity, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound) Not on hormonal treatment for at least 3 months prior Willing to follow up for 6 months Able to understand and communicate in Hindi, Gujarati, English for proper follow-up and questionnaire completion Able to provide informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Change in serum FSH/LH ratio from baseline to 12 months (or end of treatment), measured in a certified laboratory.Timepoint: 12 month	—

Secondary

Measure	Time frame
1. Menstrual Regularity: Improvement in cycle pattern assessed using Menstrual Regularity Score (MRS) over the 12-month study period. 2. Hirsutism: Change in severity assessed by the Ferriman-Gallwey score. 3. Acne: Change in severity assessed by GAG (Global Acne Grading) Score. 4. Emotional Health: Changes in depression, anxiety, and stress levels measured by DASS-21 scale. 5. Body Weight/BMI: Change in BMI from baseline to end of treatment.Timepoint: 12 month	—

Measure

Time frame

1. Menstrual Regularity: Improvement in cycle pattern assessed using Menstrual Regularity Score (MRS) over the 12-month study period. 2. Hirsutism: Change in severity assessed by the Ferriman-Gallwey score. 3. Acne: Change in severity assessed by GAG (Global Acne Grading) Score. 4. Emotional Health: Changes in depression, anxiety, and stress levels measured by DASS-21 scale. 5. Body Weight/BMI: Change in BMI from baseline to end of treatment.Timepoint: 12 month

—

Countries

India

Contacts

Public ContactVataliya Mansi Mukeshbhai

Rajkot Homoeopathic Medical College

Vanioza8@gmail.com9428052673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026